Pfizer Inc (PFE) 33.97 $PFE 3 Little-Known Stocks I'm

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 33.97 $PFE

3 Little-Known Stocks I'm Glad I Bought
Todd Campbell, The Motley Fool - Motley Fool - Sun Mar 08, 12:04PM CDT
Source: Flickr user stockmonkeys.com. Investing in clinical-stage biotech stocks isn't for the faint of heart. The industry's jaw-dropping pops and drops can be so dramatic as to suit these stocks only the most speculative portion of an investor's...
JNJ: 100.11 (-2.41), INSY: 57.69 (+0.08), PTLA: 41.72 (-0.13), PFE: 33.97 (-0.50), OPHT: 53.19 (-0.29), BMY: 65.12 (-0.93), REGN: 422.13 (-6.82), NVS: 97.46 (-1.49)

Did Pfizer Inc. Just Gut Its Chances of Finding New Blockbusters?
Todd Campbell, The Motley Fool - Motley Fool - Sun Mar 08, 8:59AM CDT
Source: Pfizer, via Facebook. Pfizer Inc.  and other big drugmakers have a problem on their hands. Facing a steady stream of patent expirations on top-selling medicines, they're caught in a tug-of-war between developing next-generation therapies...
PFE: 33.97 (-0.50), MRK: 56.84 (-1.14), HSP: 87.90 (+0.05)

2 Tiny Biotechs That Could Have Blockbuster Opportunity
Todd Campbell and Michael Douglass, The Motley Fool - Motley Fool - Sat Mar 07, 9:11AM CST
Smaller health care stocks are not for the faint of heart. When it comes to developing and testing new drugs, the success rate is tiny but the rewards can be huge. How can the risk-tolerant Fool spot the next Amgen or Biogen ? This health care...
JNJ: 100.11 (-2.41), BIIB: 417.63 (-7.98), PTLA: 41.72 (-0.13), PFE: 33.97 (-0.50), OPHT: 53.19 (-0.29), AMGN: 154.88 (-4.72), BMY: 65.12 (-0.93), NVS: 97.46 (-1.49), CELG: 118.03 (-2.68)

6.86% Advantage To 5 Dow Highest Yield, Lowest Price, March Dogs With Coca-Cola
Fredrik Arnold - at Seeking Alpha - Sat Mar 07, 7:28AM CST

KO: 41.52 (-0.88), T: 33.48 (-0.52), GE: 25.42 (-0.40), PFE: 33.97 (-0.50), MRK: 56.84 (-1.14), XOM: 85.63 (-1.11), MCD: 97.13 (-1.98), CAT: 80.06 (-1.45), CVX: 103.55 (-1.18), VZ: 48.29 (-0.63)

12.88% Edge To 5 Dow Highest Yield, Lowest Price, March Dogs With Procter & Gamble
Fredrik Arnold - at Seeking Alpha - Sat Mar 07, 5:59AM CST

T: 33.48 (-0.52), GE: 25.42 (-0.40), PFE: 33.97 (-0.50), MRK: 56.84 (-1.14), XOM: 85.63 (-1.11), MCD: 97.13 (-1.98), PG: 82.66 (-1.97), CAT: 80.06 (-1.45), CVX: 103.55 (-1.18), VZ: 48.29 (-0.63)

Top 10 Dow Dividend Dogs Disport 8.21% To 16.12% Upsides In March
Fredrik Arnold - at Seeking Alpha - Sat Mar 07, 4:15AM CST

KO: 41.52 (-0.88), GE: 25.42 (-0.40), AXP: 80.31 (-0.84), UTX: 119.43 (-1.36), PFE: 33.97 (-0.50), INTC: 33.19 (-0.54), T: 33.48 (-0.52), JNJ: 100.11 (-2.41), JPM: 60.89 (-1.11), MRK: 56.84 (-1.14), MCD: 97.13 (-1.98), PG: 82.66 (-1.97), CAT: 80.06 (-1.45), CVX: 103.55 (-1.18), MSFT: 42.36 (-0.75), VZ: 48.29 (-0.63)

Seeking Alpha's Biotech Weekly: AbbVie - Pharmacyclitics, Orexigen Confusion, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Mar 06, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
PCYC: 254.56 (+0.34), MDT: 76.48 (-2.02), ARWR: 7.75 (-0.19), SPHS: 0.70 (-0.03), BSX: 16.56 (-0.41), MDVN: 126.55 (-0.53), JNJ: 100.11 (-2.41), AAC: 29.30 (-2.80), ABBV: 55.64 (-1.22), SNY: 47.42 (-0.94), SMMT: 10.29 (+0.10), ARNA: 4.32 (+0.09), XLRN: 40.55 (-0.79), MNK: 121.33 (-0.37), AQXP: 10.49 (+0.43), PFE: 33.97 (-0.50), AMGN: 154.88 (-4.72), GSK: 46.73 (-0.87), BMY: 65.12 (-0.93), MNKD: 5.47 (-0.26), CELG: 118.03 (-2.68), OREX: 7.10 (-0.91), PODD: 32.24 (+0.26), GERN: 3.50 (-0.28), TEVA: 56.40 (-0.11), TCON: 17.57 (+0.36), NVS: 97.46 (-1.49)

3 Big Pharma Stocks to Buy in March
Brian Orelli, Dan Caplinger, and Todd Campbell, The Motley Fool - Motley Fool - Fri Mar 06, 2:16PM CST
With the Ides of March approaching, we asked our team of Fool.com healthcare contributors to identify big pharma stocks that look like good picks this month. Read on to see why Dan, Todd, and Brian think  Pfizer , Bristol-Myers Squibb , and ...
JNJ: 100.11 (-2.41), PFE: 33.97 (-0.50), BMY: 65.12 (-0.93)

Regeneron Jumps Ahead In $10 Billion Race For Next Generation Cardio Drugs
Cheryl Swanson - at Seeking Alpha - Fri Mar 06, 1:35PM CST

PFE: 33.97 (-0.50), AMGN: 154.88 (-4.72), SNY: 47.42 (-0.94), REGN: 422.13 (-6.82)

3 Prevailing Myths About Dividend Stocks
Motley Fool Staff - Motley Fool - Fri Mar 06, 7:15AM CST
Are higher dividend yields always better than low ones? Are dividend stocks always safe? And are all dividends taxed the same? Dividend investing can be one of the most certain paths toward long-term wealth, but it's important to separate fact from...
GE: 25.42 (-0.40), PFE: 33.97 (-0.50), VGR: 22.50 (-0.26)

Pfizer's Strong FCF Means Big Dividend Growth
Josh Arnold - at Seeking Alpha - Fri Mar 06, 1:44AM CST

PFE: 33.97 (-0.50)

AbbVie Stock Slides On Pricey Pharmacyclics Deal
at Investor's Business Daily - Thu Mar 05, 3:56PM CST
Big pharma AbbVie's $21 billion deal to acquire hot biotech Pharmacyclics was met with widespread skepticism by AbbVie investors Thursday, sending AbbVie's stock falling 5.7% Thursday. AbbVie (ABBV) announced the cash-and-stock acquisition late...
JNJ: 100.11 (-2.41), PCYC: 254.56 (+0.34), PFE: 33.97 (-0.50), AMGN: 154.88 (-4.72), ABBV: 55.64 (-1.22), NVS: 97.46 (-1.49)

Pfizer's Prevenar Cleared in the EU for New Indication - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 05, 3:30PM CST
Pfizer Inc (PFE) announced that Prevenar 13 was approved in the EU for a new indication.
JNJ: 100.11 (-2.41), MRK: 56.84 (-1.14), PFE: 33.97 (-0.50), GSK: 46.73 (-0.87)

Stock Market News for March 05, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Mar 05, 9:10AM CST
Markets ended in the red for the second consecutive day, handing the Dow and S&P 500 their worst closing levels since Feb 19
KO: 41.52 (-0.88), MMM: 164.36 (-3.21), GE: 25.42 (-0.40), UTX: 119.43 (-1.36), PFE: 33.97 (-0.50), UNH: 112.88 (-1.91), WMT: 82.59 (-0.98), AMGN: 154.88 (-4.72), BA: 153.12 (-1.35), CELG: 118.03 (-2.68), PM: 80.05 (-1.66), ADP: 86.00 (-0.75), ABBV: 55.64 (-1.22), PG: 82.66 (-1.97)

Today's Market: Pharma Mergers And Acquisitions Impacting These Stocks
Matthew Smith - at Seeking Alpha - Thu Mar 05, 8:02AM CST

JNJ: 100.11 (-2.41), VRX: 198.71 (-5.24), PCYC: 254.56 (+0.34), PFE: 33.97 (-0.50), SLXP: 158.01 (+0.57), ABBV: 55.64 (-1.22), NVS: 97.46 (-1.49)

Merck KGaA's Q4 Net Income Flat Y/Y, Provides 2015 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 9:40AM CST
Merck KGaA's (MKGAF) net income during the fourth quarter of 2014 came in at 280 million euros compared with 280.6 million euros in the year-ago period.
PFE: 33.97 (-0.50), SLXP: 158.01 (+0.57), SCMP: 15.64 (+0.49)

3 Companies That Could Unlock Shareholder Value Through a Split or Spinoff
Motley Fool Staff - Motley Fool - Wed Mar 04, 8:08AM CST
There are a number of reasons companies might consider spinning off parts of their operations. A spinoff may happen if a company's sales are sliding and it needs to raise cash. In other cases, activist investors lobby aggressively for a spinoff after...
GE: 25.42 (-0.40), PFE: 33.97 (-0.50), CMG: 658.68 (-11.81), C: 53.06 (-0.50), SYF: 31.20 (-0.76), HSP: 87.90 (+0.05), YUM: 79.16 (-1.36)

Pfizer Inc. Has a Growth Problem -- Here Are 3 Ways to Change That
Sean Williams, The Motley Fool - Motley Fool - Wed Mar 04, 7:02AM CST
Source: Pfizer, Facebook. Pfizer might be the largest pharmaceutical products company in the world by revenue, but it looks far from a force to be reckoned with at the moment. Pfizer's problems in a nutshell Like much of the big...
ISIS: 70.44 (-1.32), JAZZ: 172.12 (-2.64), AZN: 66.27 (-1.91), PFE: 33.97 (-0.50)

Pfizer's
at Investor's Business Daily - Tue Mar 03, 5:33PM CST
Pfizer's (PFE) blockbuster vaccine Prevnar 13, which shields against 13 strains of pneumococcal disease, has been approved for use in EU residents 18 and up. Shares fell 0.6% to 34.56.
PFE: 33.97 (-0.50)

Amgen: The Best Biotech Stock You Don't Own
Dan Strack - at Seeking Alpha - Tue Mar 03, 4:04PM CST

BIIB: 417.63 (-7.98), GILD: 101.81 (-1.61), PFE: 33.97 (-0.50), MRK: 56.84 (-1.14), AMGN: 154.88 (-4.72), ABBV: 55.64 (-1.22), GSK: 46.73 (-0.87), BMY: 65.12 (-0.93), HSP: 87.90 (+0.05), NVS: 97.46 (-1.49), CELG: 118.03 (-2.68)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 33

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
Dar Global Expands Jeddah Portfolio with $267M Project

Updated Category News Views 221

Dar Global's Big Jeddah Move: A $267M Bet Alright, let's dive into what Dar Global's been up to in Saudi Arabia. They've just announced a whopping SAR 1 billion development project in Jeddah, bringing an international luxury brand to the city with an exclusive co-branded residential concept. Now that's something to chew on for any investor eyeing the Middle East's real...

Continue Reading
Salvation Army’s Angel Tree: 2026 Holiday Cheer Drive

Updated Category News Views 100

Kickstarting Holiday Generosity: The Angel Tree Program Man, there's something heartwarming about a Christmas that shines bright for everyone. The Salvation Army's Angel Tree program is back for another season, rolling up with a mission to spark joy across the country. For over 45 years now, this initiative's been the answer to many Christmas wish lists, especially for...

Continue Reading
S&P Global's Bold $2 Billion Debt Offering Details

Updated Category News Views 80

Drilling Down into S&P Global's Debt Move S&P Global's throwing its hat in the ring with a colossal $2 billion debt offering. Now, they aren't just setting it on the table — they're notably carving it up into three chunks. You’ve got $750 million at 5.600% that comes due in 2031, $600 million at 5.800% for 2034, and $650 million at a 6.000% rate maturing in 2036....

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 137

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 78

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 207

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 135

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Ontario Airport Braces for Holiday Travel Surge

Updated Category News Views 92

Gearing Up for a Thanksgiving Travel Boom Think Thanksgiving brings only turkey to the table? Down in Ontario, California, it's all about jet fuel and passenger counts. The Ontario International Airport (ONT) is where the skies are buzzing, forecasting over 227,000 passengers trying to soak up the holiday vibes by air. Compare that to the numbers when the local folks...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 90

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on Oy Rosaco Ab's Recent Transactions in Rapala VMC

Updated Category News Views 159

Understanding Recent Transactions by Oy Rosaco Ab Rapala VMC Corporation, known for its prominent role in the fishing tackle industry, recently experienced noteworthy managerial transactions attributed to Oy Rosaco Ab. These transactions, which occurred on a specific date, highlight the financial activities that often play a vital role in influencing stock decisions and...

Continue Reading
Altria's Board Welcomes Richard S. Stoddart as New Director

Updated Category News Views 219

Richard S. Stoddart Joins Altria’s Board of Directors Altria Group, Inc. (NYSE: MO) has made an exciting announcement regarding the expansion of its Board of Directors. The company is pleased to welcome Richard S. Stoddart, who will officially join the board soon. His significant background in leadership roles across various sectors will be a valuable addition as Altria...

Continue Reading
Exploring the Growth of Modular Building Systems Market

Updated Category News Views 220

Understanding the Rise of Panelized Modular Building Systems The panelized modular building systems market is on a remarkable trajectory, projected to grow significantly over the next few years. With a forecasted increase of around USD 47.7 billion driven by technological advancements and the quest for cost efficiency, this market is becoming a focal point for the...

Continue Reading
Inspire Veterinary Partners Faces Stock Decline and Strategic Moves

Updated Category News Views 141

Inspire Veterinary Partners Hits a 52-Week Low Inspire Veterinary Partners has found itself in a precarious position as its stock price has plunged to a troubling 52-week low of $0.23. This significant drop, amounting to a staggering 99.76% decline over the past year, has sent ripples of concern among its investors. As the company struggles amid market challenges and...

Continue Reading
Collaborative Initiatives in STEM Education Introduced

Updated Category News Views 117

Pitsco Education Partners with Study Smart Tutors Pitsco Education and Study Smart Tutors have announced a strategic partnership aimed at enhancing STEM education across various learning environments. This collaboration seeks to integrate the strengths of both organizations, providing educators and students with unique resources and opportunities. By combining Pitsco's...

Continue Reading